Aβ transport studies were performed as we previously reported (Qosa et al., 2014a (
link); Qosa et al., 2014b (
link)). bEnd3 cells were plated on 0.45 μm polyester membrane transwell 24-well plates, then treated with the compounds (10 μM) on day five for 24 h. Next day, Aβ
40 transport assay was initiated by addition of a mixture of 0.1 nM
125I-Aβ
40 and 0.05 mM
14C-inulin in media to the B-side. At the end of incubation period, 30 min, aliquots from both sides were separately collected for radioactivity analysis using
Wallac 1470 Wizard Gamma and Wallac 1414 WinSpectral Liquid Scintillation Beta Counter (PerkinElmer; Waltham, MA). The transport quotients of
125I-Aβ
40 (TQ
B→A) was calculated using the following equation (Qosa et al., 2014a (
link); Qosa et al., 2014b (
link)):
where Aβ
40 (A) is the cpm of
125I-Aβ
40 in the upper side, and Aβ
40 (B) is the cpm of
125I-Aβ
40 in the lower side, inulin (A) is the dpm of
14C-inulin in the upper side, and inulin (B) is the dpm of
14C-inulin in the lower side. Three independent experiments were carried out for each compound.
Concentration-dependent studies for Aβ transport across the monolayer was performed for Tph in the concentration range between 1–10 μM as described above.
Elfakhri K.H., Duong Q.V., Langley C., Depaula A., Mousa Y.M., Lebeouf T., Cain C, & Kaddoumi A. (2018). Characterization of Hit Compounds Identified from High-Throughput Screening for their Effect on Blood-Brain Barrier Integrity and Amyloid-β Clearance: In vitro and in vivo Studies. Neuroscience, 379, 269-280.